While in other cancers, these hallmarks can be established by driver mutations, HTLV-1 induced tumorigenesis is driven by the expression of the viral oncogene, HTLV-1 Tax, which induces a potent inflammatory response through the NF-κB pathway [52, 53]. The gene discussed is CNTN2; the disease is cancer.